GoKawiilWarhound raises $200M to genetically engineer and clone military working dogs
Warhound, backed by Colossal Biosciences' Ben Lamm and Anduril's Palmer Luckey, has raised $200 million to genetically edit and clone top-performing military, police and first-responder dogs, mostly Belgian Malinois. Lamm says the startup has begun editing genes from donor dog cell samples, initially targeting breed-specific health issues like hip dysplasia and cancer, with plans to later enhance traits like speed and smell. Anduril will supply protective gear such as vests and goggles rather than cybernetic enhancements, while Colossal holds equity and Lamm sits on Warhound's board.
GoKawiil's interpretation of the reporting above, not reported fact.
The venture links de-extinction and gene-editing science with military contracting networks already building AI and battlefield systems for the Pentagon, suggesting a broader push to apply biotech to defense applications. Because the editing could later extend beyond disease prevention to performance enhancement, it raises questions about how far genetic modification of working animals might go. The involvement of figures tied to Anduril and Palantir points to deepening ties between Silicon Valley defense contractors and biotech startups.
- Warhound raised $200 million to genetically engineer and clone military working dogs.
- Initial gene edits target breed-specific diseases, with future plans for speed and sensory enhancements.
- Anduril will provide protective gear, not genetic engineering, and has no equity stake in Warhound.
Source: engadget.com — Mariella Moon, 2026-10-23
Published there as: “A startup called Warhound is genetically engineering dogs for the military”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.